Author： Prandoni Paolo Barbar Sofia Vedovetto Valentina Milan Marta Filippi Lucia Campello Elena Spiezia Luca
Publisher： Future Medicine
ISSN： 2044-9038
Source： Clinical Practice, Vol.10, Iss.5, 2013-09, pp. : 607-613
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treatment of Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :
Access to resources
Recommend
Symptomatic Endpoints for Venous Thromboembolism Treatment
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :
The Role of Ximelagatran in the Treatment of Venous Thromboembolism
Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 1, 2005-04 ,pp. :
Treatment of venous thromboembolism: experience with bemiparin
Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 5-6, 2003-08 ,pp. :
Treatment of Venous Thromboembolism in Cancer Patients
Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. :